Tilray Medical, a division of Tilray Brands, Inc. ("Tilray Brands") and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make ...
Merck & Co. licensed an experimental cancer antibody from a closely held Chinese company in a deal worth $588 million upfront ...
Merck has signed a licensing agreement worth up to $3.3 billion with Shanghai-based LaNova Medicines to develop, make and ...
Merck's undervalued stock presents growth opportunities with Keytruda and promising pipeline drugs, making it a Buy despite ...
Wolfe Research initiated coverage of Merck (MRK) with a Peer Perform rating. The firm said the main sentiment driver for Merck is ...
Merck & Co Inc. (MRK) and LaNova Medicines Ltd., a privately held clinical-stage biotechnology company Thursday said Merck has ...
Merck reported third-quarter earnings growth above expectations, helped by lower spending and a positive performance in ...
Q3 2024 Earnings Conference Call November 14, 2024 8:00 AM ETCompany ParticipantsConstantin Fest - Head of Investor ...
The fine chemical sector in Europe is witnessing a notable transformation, primarily fueled by the pharmaceutical industry ...
South-East Asia will now have its first dedicated Process Technology show with the launch of Process Innovation Asia Pacific ...
New York, USA, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Market Overview: The market for Zollinger-Ellison syndrome treatment is on a ...
Der Protein-Multiplex-Assay-Technologie -Marktbericht bewertet die wichtigen Merkmale des Marktes anhand der Analyse verschiedener Faktoren wie Angebot, Nachfrage, Machbarkeit und aktuelle Trends. Der ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback